400 related articles for article (PubMed ID: 29295966)
1. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
[TBL] [Abstract][Full Text] [Related]
2. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
[TBL] [Abstract][Full Text] [Related]
3. Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls.
Phillips CO; Syed Y; Parthaláin NM; Zwiggelaar R; Claypole TC; Lewis KE
J Breath Res; 2012 Sep; 6(3):036003. PubMed ID: 22759349
[TBL] [Abstract][Full Text] [Related]
4. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
[TBL] [Abstract][Full Text] [Related]
5. Can exhaled volatile organic compounds predict asthma exacerbations in children?
van Vliet D; Smolinska A; Jöbsis Q; Rosias P; Muris J; Dallinga J; Dompeling E; van Schooten FJ
J Breath Res; 2017 Mar; 11(1):016016. PubMed ID: 28102830
[TBL] [Abstract][Full Text] [Related]
6. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
[TBL] [Abstract][Full Text] [Related]
7. Measurement of exhaled volatile organic compounds from patients with chronic obstructive pulmonary disease (COPD) using closed gas loop GC-IMS and GC-APCI-MS.
Allers M; Langejuergen J; Gaida A; Holz O; Schuchardt S; Hohlfeld JM; Zimmermann S
J Breath Res; 2016 Apr; 10(2):026004. PubMed ID: 27058460
[TBL] [Abstract][Full Text] [Related]
8. Exhaled breath temperature in patients with stable and exacerbated COPD.
Lázár Z; Bikov A; Martinovszky F; Gálffy G; Losonczy G; Horváth I
J Breath Res; 2014 Sep; 8(4):046002. PubMed ID: 25234010
[TBL] [Abstract][Full Text] [Related]
9. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
10. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
[TBL] [Abstract][Full Text] [Related]
11. Study of 5 Volatile Organic Compounds in Exhaled Breath in Chronic Obstructive Pulmonary Disease.
Jareño-Esteban JJ; Muñoz-Lucas MÁ; Gómez-Martín Ó; Utrilla-Trigo S; Gutiérrez-Ortega C; Aguilar-Ros A; Collado-Yurrita L; Callol-Sánchez LM
Arch Bronconeumol; 2017 May; 53(5):251-256. PubMed ID: 27780574
[TBL] [Abstract][Full Text] [Related]
12. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
13. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
[TBL] [Abstract][Full Text] [Related]
14. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of breath analysis and detection of volatile organic compounds in COPD.
Christiansen A; Davidsen JR; Titlestad I; Vestbo J; Baumbach J
J Breath Res; 2016 Aug; 10(3):034002. PubMed ID: 27578038
[TBL] [Abstract][Full Text] [Related]
16. Observation of nonanoic acid and aldehydes in exhaled breath of patients with lung cancer.
Callol-Sanchez L; Munoz-Lucas MA; Gomez-Martin O; Maldonado-Sanz JA; Civera-Tejuca C; Gutierrez-Ortega C; Rodriguez-Trigo G; Jareno-Esteban J
J Breath Res; 2017 Apr; 11(2):026004. PubMed ID: 28440225
[TBL] [Abstract][Full Text] [Related]
17. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers.
Basanta M; Jarvis RM; Xu Y; Blackburn G; Tal-Singer R; Woodcock A; Singh D; Goodacre R; Thomas CL; Fowler SJ
Analyst; 2010 Feb; 135(2):315-20. PubMed ID: 20098764
[TBL] [Abstract][Full Text] [Related]
19. Geographical variation in the exhaled volatile organic compounds.
Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
[TBL] [Abstract][Full Text] [Related]
20. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
